Holen Sie sich die Stockscreener-App
14.96
0.07%
-0.010
Schlusskurs vom Vortag:
$14.97
Offen:
$14.86
24-Stunden-Volumen:
116.37K
Relative Volume:
1.01
Marktkapitalisierung:
$1.34B
Einnahmen:
$661.97M
Nettoeinkommen (Verlust:
$136.88M
KGV:
10.39
EPS:
1.4396
Netto-Cashflow:
$159.27M
1W Leistung:
+0.13%
1M Leistung:
+11.48%
6M Leistung:
-2.54%
1J Leistung:
-18.74%
1-Tages-Spanne:
$14.79
$15.26
1-Wochen-Bereich:
$14.52
$15.26
52-Wochen-Spanne:
$13.00
$19.90
Afya Ltd Stock (AFYA) Company Profile
Compare AFYA vs EDU, TAL, LAUR, LOPE, GHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AFYA
Afya Ltd
|
14.96 | 1.34B | 661.97M | 136.88M | 159.27M | 1.4396 |
EDU
New Oriental Education Technology Group Inc Adr
|
56.42 | 8.98B | 5.15B | 405.45M | 918.66M | 2.3741 |
TAL
Tal Education Group Adr
|
11.20 | 6.82B | 2.82B | 278.91M | 591.92M | 0.4868 |
LAUR
Laureate Education Inc
|
33.56 | 4.79B | 1.70B | 283.82M | 263.15M | 1.9154 |
LOPE
Grand Canyon Education Inc
|
171.36 | 4.65B | 1.11B | 216.17M | 238.59M | 7.7173 |
GHC
Graham Holdings Co
|
1,060.93 | 4.61B | 4.91B | 301.63M | 267.66M | 66.42 |
Afya Ltd Stock (AFYA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2026-02-13 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2026-01-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-09-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-09-08 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-06 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2025-07-29 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-03-11 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-31 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-12-03 | Eingeleitet | Goldman | Sell |
| 2024-08-30 | Eingeleitet | UBS | Neutral |
| 2024-01-29 | Eingeleitet | Citigroup | Neutral |
| 2024-01-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-10-13 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-07-21 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-15 | Hochstufung | UBS | Neutral → Buy |
| 2021-02-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-28 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-15 | Fortgesetzt | BofA Securities | Buy |
| 2020-08-19 | Eingeleitet | Credit Suisse | Neutral |
| 2020-05-20 | Herabstufung | UBS | Buy → Neutral |
| 2020-03-20 | Hochstufung | Itau BBA | Market Perform → Outperform |
| 2020-01-23 | Fortgesetzt | BofA/Merrill | Buy |
| 2019-09-19 | Eingeleitet | UBS | Buy |
| 2019-08-13 | Eingeleitet | BofA/Merrill | Buy |
| 2019-08-13 | Eingeleitet | Goldman | Neutral |
| 2019-08-13 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-08-09 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Afya Ltd Aktie (AFYA) Neueste Nachrichten
Afya Limited (NASDAQ:AFYA) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Afya Limited (NASDAQ:AFYA) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Afya (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon Sells 2,320 Shares - MarketBeat
Afya (AFYA) CEO sells 21,820 shares, retains significant stake - Stock Titan
Afya (Nasdaq: AFYA) flags Brazil tax, PROUNI/FIES and MEC exam risks - Stock Titan
Afya (AFYA) CEO trims holdings with 1,810-share open-market sale - Stock Titan
Afya (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon Sells 3,900 Shares of Stock - Defense World
Afya (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon Sells 800 Shares - MarketBeat
Virgilio Deloy Capobian Gibbon Sells 3,900 Shares of Afya (NASDAQ:AFYA) Stock - MarketBeat
XP Investments lists 36,000 S-8 shares for sale (NASDAQ: AFYA) - Stock Titan
Afya (AFYA) CEO sells 4,700 Class A shares, retains over 350,000 total - Stock Titan
AFYA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Should Value Investors Buy Afya (AFYA) Stock? - Yahoo Finance
Afya (NASDAQ:AFYA) Shares Gap DownShould You Sell? - MarketBeat
Afya Limited (NASDAQ: AFYA) files Form 144 proposing sale of Class A shares - Stock Titan
[Form 3/A] Afya Ltd Amended Initial Statement of Beneficial Ownership - Stock Titan
Afya Limited (NASDAQ:AFYA) Plans Annual Dividend of $0.66 - MarketBeat
AFYA News & Events - Intellectia AI
Afya (AFYA) vice president details options, RSUs and 43,032 shares - Stock Titan
Afya (AFYA) VP details stock options, RSUs and share holdings - Stock Titan
Afya (AFYA) director Marcelo Ken Suhara files initial Form 3 ownership report - Stock Titan
Afya (NASDAQ: AFYA) VP Del Bianco lists stock, option and RSU stakes - Stock Titan
Afya (AFYA) director files initial insider ownership report with no trades - Stock Titan
Afya (NASDAQ: AFYA) VP details initial share, option and RSU holdings - Stock Titan
Afya (AFYA) controller discloses stock options, RSUs and shares - Stock Titan
Afya (AFYA) vice president discloses initial share, RSU and option stakes - Stock Titan
Afya (AFYA) CEO details shares, options and RSUs in initial Form 3 - Stock Titan
Afya (AFYA) vice president reports stock options, RSUs and share stake - Stock Titan
Afya (AFYA) director Christina Bacon Krebs files initial insider Form 3 - Stock Titan
Afya (AFYA) VP details Class A shares, options and RSU holdings - Stock Titan
Afya (NASDAQ: AFYA) director Carvalho reports initial direct and indirect stakes - Stock Titan
Afya (AFYA) director discloses 1.26M Class A share stake - Stock Titan
Afya (NASDAQ: AFYA) CFO reports option, RSU and share holdings - Stock Titan
Afya Ltd (AFYA) director Krafft Kay Christian submits initial Form 3 - Stock Titan
Afya Ltd (AFYA) director Pereira de Paula Miguel Filisbino files Form 3 - Stock Titan
Afya (AFYA) director Vanessa Claro Lopes files Form 3 ownership report - Stock Titan
Afya (AFYA) director identified as reporting insider in Form 3 filing - Stock Titan
Afya Limited (NASDAQ:AFYA) Sees Significant Growth in Short Interest - MarketBeat
AFYA SEC FilingsAfya Limited 10-K, 10-Q, 8-K Forms - Stock Titan
Afya (AFYA) affiliate plans sale of 150,000 Class A shares on Nasdaq - Stock Titan
Doma Perpetual Capital Management LLC Boosts Position in Afya Limited $AFYA - MarketBeat
Bamco Inc. NY Cuts Stock Holdings in Afya Limited $AFYA - MarketBeat
Afya (NASDAQ:AFYA) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
Afya Ltd (AFYA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments By GuruFocus - Investing.com Canada
Afya Limited 2025 Q4ResultsEarnings Call Presentation (NASDAQ:AFYA) 2026-03-13 - Seeking Alpha
Earnings Call Summary | Afya Ltd(AFYA.US) Q4 2025 Earnings Conference - 富途牛牛
Afya Q4 2025 Earnings: $32.5M Net Income, $169M Revenue | Full Year ResultsNews and Statistics - IndexBox
Afya Ltd. Hits New 52-Week Low at USD 13.01 Amid Decline - Markets Mojo
Afya Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Afya: Q4 Financial Results Overview - Bitget
Afya: Q4 Earnings Snapshot - WHAS11
Finanzdaten der Afya Ltd-Aktie (AFYA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Afya Ltd-Aktie (AFYA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gibbon Virgilio Deloy Capobian | Chief Executive Officer |
Mar 31 '26 |
Sale |
14.92 |
2,320 |
34,614 |
149,618 |
| Gibbon Virgilio Deloy Capobian | Chief Executive Officer |
Mar 30 '26 |
Sale |
14.91 |
1,510 |
22,514 |
151,938 |
| Gibbon Virgilio Deloy Capobian | Chief Executive Officer |
Mar 27 '26 |
Sale |
15.00 |
300 |
4,500 |
153,448 |
0.84%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):